Hemab Therapeutics Holdings, Inc. (COAG) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading COAG…

Hemab Therapeutics Holdings, Inc. (COAG) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Hemab Therapeutics Holdings, Inc.

COAG · CIK 2114044

4 · Sep 25, 2026 · Director Walbert Keli was granted 36K Stock Option (Right to Buy)

4

Director Walbert Keli was granted 36K Stock Option (Right to Buy)

Filed: Sep 25, 2026
Period: Sep 24, 2026
Accession: 0001193125-26-402936
Filer: Hemab Therapeutics Holdings, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov